Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial
Todd Dewey(Medical City Dallas Hospital), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Vasilis Babaliaros(Valve (United States)), E. Murat Tuzcu(Cleveland Clinic), D. Craig Miller(Harvard University), Isaac George(Columbia University), Lars G. Svensson(Cleveland Clinic), Jeffrey Tyner(Scripps Health), Raj Makkar(Cedars-Sinai Medical Center), Ajay J. Kirtane(Columbia University Irving Medical Center), Bruce Bowers, Gregory P. Fontana(HCA Healthcare), Mathew Williams(Mount Sinai Health System), David L. Brown(Baylor Scott & White Health), Martin B. Leon(Columbia University Irving Medical Center), Craig R. Smith(University of Arizona), Vinod H. Thourani(Valve (United States)), Paul S. Teirstein(Scripps Health), Joseph E. Bavaria(University of Pennsylvania)
Cited by 57
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k